AC
OVID icon

AWH Capital’s Ovid Therapeutics OVID Stock Holding History

AWH Capital’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-224,500
Closed -$1.29M – 43
2020
Q3 		$1.29M Buy
+224,500
New +$1.5M 1.81% 22
2020
Q1 		– Sell
-305,000
Closed -$1.27M – 25
2019
Q4 		$1.27M Buy
305,000
+45,000
+17% +$142K 1.47% 19
2019
Q3 		$842K Buy
260,000
+5,000
+2% +$11.4K 1.06% 20
2019
Q2 		$472K Buy
255,000
+25,000
+11% +$44.6K 0.68% 19
2019
Q1 		$407K Buy
+230,000
New +$575K 0.69% 19

Other funds holding OVID

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AWH Capital's OVID Position: Q4 2020 in Review

AWH Capital sold out of Ovid Therapeutics (OVID) in Q4 2020, closing a stake of 224,500 shares — an estimated $1.29M sold.

AWH Capital first reported a position in OVID in Q1 2019 and held it in 5 quarters. The position peaked at $1.29M in Q3 2020. 83 funds tracked by Wall St. Rank hold OVID as of Q4 2020.

  • AWH Capital reported no remaining Ovid Therapeutics position as of Q4 2020 after selling out during the quarter.
  • AWH Capital sold 224,500 Ovid Therapeutics shares in Q4 2020, an estimated $1.29M.
  • AWH Capital first reported a position in Ovid Therapeutics in Q1 2019 and held it in 5 quarters.
  • AWH Capital's Ovid Therapeutics position peaked at $1.29M in Q3 2020.
  • 83 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q4 2020.

Based on AWH Capital's 13F filing for Q4 2020, filed 16 Feb 2021.